Injective Rebounds from August Low, Eyes $15 Target

Injective (INJ) has rebounded from its August low of $3.95, demonstrating signs of a potential bullish trend reversal.

The token's technical indicators and on-chain data are pointing toward renewed investor confidence, with momentum indicators aligning with the ongoing recovery.

Analyst Moe identified $15 as a possible upside target if the positive momentum continues, but cautioned that further gains are contingent on sustained upward momentum and confirming breakouts above identified resistance levels.